Wanbang Biopharmaceuticals specializes in the development, production, and distribution of pharmaceuticals tailored to patients with diabetes and associated cardiovascular conditions. Its range of products encompasses animal insulin, Glimepiride tablets, Meglumine Adenosine Cyclophosphate, EPO, Bangtan (Telmisatan), and Heparin sodium. In addition, the company offers aloe compound capsules designed to promote liver-heat clearance and bowel relaxation, among other benefits.